source
- Novartis to acquire ADC developer in a deal worth up to $1.5BThe deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.BioPharma Dive · 24d ago↗ source
- STAT+: Four major biotech updates to catch up onAnthropic CEO talks drug discovery, Medicare proposes steep 340B drug payment cuts, and more biotech newsSTAT · 24d ago↗ source
- Cancer, immune drugmakers dominate VC funding so far in 2026Drug developers focusing on either disease area made up more than 40% of the number of biotech companies and amount raised so far in 2026, per BioPharma Dive data.BioPharma Dive · 24d ago↗ source